Now showing items 31-40 of 67
Diversity of the angiogenic phenotype in non-small cell lung cancer
(American Thoracic Society, 2007)
Timing of lung transplantation for patients with fibrotic lung diseases
(Thieme Medical Publishers, Inc., 2002)
Macrophage migration inhibitory factor (MIF) and CXC chemokine expression in non-small cell lung cancer (NSCLC): Role in angiogenesis and prognosis
(American Association for Cancer Research, 2003)
Prostaglandin E2 inhibits fibroblast migration by EP2 receptor-mediated increase in PTEN activity
(American Thoracic Society, 2005)
An essential role for CCAAT/enhancer binding protein Β in bleomycin-induced pulmonary fibrosis No conflicts of interest were declared.
(John Wiley & Sons, Ltd., 2007-03)
Pulmonary fibrosis is characterized by inflammation, genesis of myofibroblasts, and abnormal tissue repair. Despite extensive research, its pathogenesis remains incompletely understood. Previously, the transcription factor ...
Prognostic factors in oral cavity and oropharyngeal squamous cell carcinoma
(Wiley Subscription Services, Inc., A Wiley Company, 2004-12-15)
BACKGROUND The survival of patients with head and neck squamous cell carcinoma (HNSCC) remains unaffected despite recent therapeutic advances. To reverse this trend, reliable and clinically applicable markers of tumor ...
Monocyte-fibronectin interactions, via a5b_1 integrin, induce expression of CXC chemokine-dependent angiogenic activity
(American Association of Immunologists, 2001)
Cost-effectiveness of Implementing Low-Tidal Volume Ventilation in Patients With Acute Lung Injury
(American College of Chest Physicians, 2009)
Background: Despite widespread guidelines recommending the use of lung-protective ventilation (LPV) in patients with acute lung injury (ALI), many patients do not receive this lifesaving therapy. We sought to estimate the ...